News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,171 Results
Type
Article (42164)
Company Profile (294)
Press Release (669713)
Section
Business (210297)
Career Advice (2089)
Deals (36615)
Drug Delivery (105)
Drug Development (82949)
Employer Resources (172)
FDA (16530)
Job Trends (15381)
News (355739)
Policy (33857)
Tag
Academia (2579)
Alliances (51317)
Alzheimer's disease (1332)
Approvals (16511)
Artificial intelligence (214)
Bankruptcy (367)
Best Places to Work (11771)
Biotechnology (188)
Breast cancer (228)
Cancer (1741)
Cardiovascular disease (135)
Career advice (1746)
Cell therapy (357)
Clinical research (66793)
Collaboration (677)
Compensation (375)
COVID-19 (2635)
C-suite (163)
Data (1640)
Diabetes (214)
Diagnostics (6367)
Earnings (87128)
Employer resources (149)
Events (113733)
Executive appointments (577)
FDA (17449)
Funding (611)
Gene therapy (258)
GLP-1 (684)
Government (4478)
Healthcare (18951)
Infectious disease (2747)
Inflammatory bowel disease (124)
Interviews (321)
IPO (16737)
Job creations (4054)
Job search strategy (1490)
Layoffs (460)
Legal (8353)
Lung cancer (257)
Manufacturing (245)
Medical device (13347)
Medtech (13352)
Mergers & acquisitions (20245)
Metabolic disorders (568)
Neuroscience (1750)
NextGen: Class of 2025 (6634)
Non-profit (4523)
Northern California (2100)
Obesity (318)
Opinion (218)
Patents (166)
People (58797)
Phase I (20708)
Phase II (29401)
Phase III (22017)
Pipeline (717)
Postmarket research (2653)
Preclinical (8760)
Radiopharmaceuticals (246)
Rare diseases (336)
Real estate (6248)
Regulatory (22774)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1801)
Startups (3717)
United States (18653)
Vaccines (631)
Weight loss (224)
Date
Last 7 days (604)
Last 30 days (2469)
Last 365 days (34915)
2025 (4512)
2024 (35769)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (779)
Arizona (218)
Asia (40385)
Australia (6469)
California (4794)
Canada (1723)
China (402)
Colorado (220)
Connecticut (231)
Europe (86060)
Florida (691)
Georgia (165)
Illinois (466)
Indiana (268)
Japan (125)
Maryland (748)
Massachusetts (3662)
Michigan (200)
Minnesota (336)
New Jersey (1363)
New York (1366)
North Carolina (852)
Northern California (2100)
Ohio (173)
Pennsylvania (1104)
South America (1159)
Southern California (1801)
Texas (711)
Utah (145)
Washington State (474)
712,171 Results for "cantabio pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease
Cantabio Pharmaceuticals, Inc. announced that The Michael J. Fox Foundation for Parkinson’s Research has awarded the Company a major grant for a project entitled “Development of Cell-penetrant DJ-1 Protein as a Therapeutic Candidate for Treatment of Parkinson’s Disease.” This grant supports the Company’s ongoing cell-penetrant DJ-1 protein replacement therapeutic program.
February 6, 2024
·
3 min read
Biotech Bay
Cantabio Pharmaceuticals Receives Additional Grant from The Michael J. Fox Foundation for Testing Its Novel Redox DJ-1 Protein-based ELISA Platform for the Diagnosis of Parkinson’s Disease
Cantabio Pharmaceuticals, Inc. announced that The Michael J. Fox Foundation for Parkinson’s Research has awarded the Company a major grant entitled “Quantification of Cys106 of DJ-1 in Distinct Redox States in Parkinson’s Patients’ iPSC-derived Dopaminergic Neurons, Postmortem Brain Tissue and Plasma as a Potential Biomarker of Parkinson’s Disease”.
August 17, 2023
·
4 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%
February 13, 2025
·
1 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025
February 7, 2025
·
4 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
Press Releases
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
February 20, 2025
·
2 min read
Press Releases
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
·
3 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
February 17, 2025
·
12 min read
1 of 71,218
Next
